BIOTECHNOLOGY INNOVATION ORGANIZATION

Lobbying client · District of Columbia · filed 2025 to 2026

Advocacy organization for the biotechnology industry.

$300,000 Reported spend

6 Filings counted

1 Firms hired

3 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (67186), not by name.

Firms hired 1

DLA PIPER LLP (US) $300,000 6 filings

Bills named in these filings 3

HR 1262
Mikaela Naylon Give Kids a Chance Act

4 filings
HR 946
ORPHAN Cures Act

4 filings
S 932
Give Kids a Chance Act of 2025

4 filings

Reported by year 2 years

2026 $120,000 2 filings
2025 $180,000 4 filings

Issues lobbied 4

Health Issues 6
Medical/Disease Research/Clinical Labs 6
Medicare/Medicaid 6
Pharmacy 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Food & Drug Administration (FDA) 5
HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 6 total

Q2

DLA PIPER LLP (US)

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 17, 2026

View → Q1

DLA PIPER LLP (US)

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 20, 2026

View → Q4

DLA PIPER LLP (US)

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 16, 2026

View → Q3

DLA PIPER LLP (US)

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 16, 2025

View → Q2

DLA PIPER LLP (US)

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $60,000 income · posted Jul 21, 2025

View → RR

DLA PIPER LLP (US)

2nd Quarter (Apr 1 - June 30) 2025 · posted Jun 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.